EIF1B | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	35 studies	40% ± 13%	Explore
fibroblast	35 studies	40% ± 16%	Explore
endothelial cell	32 studies	33% ± 13%	Explore
natural killer cell	30 studies	27% ± 8%	Explore
pericyte	27 studies	40% ± 14%	Explore
macrophage	26 studies	29% ± 8%	Explore
smooth muscle cell	25 studies	41% ± 13%	Explore
CD8-positive, alpha-beta T cell	25 studies	26% ± 8%	Explore
classical monocyte	24 studies	34% ± 13%	Explore
CD4-positive, alpha-beta T cell	24 studies	27% ± 8%	Explore
T cell	22 studies	27% ± 12%	Explore
conventional dendritic cell	21 studies	31% ± 16%	Explore
memory B cell	20 studies	36% ± 11%	Explore
naive B cell	20 studies	38% ± 13%	Explore
non-classical monocyte	20 studies	33% ± 14%	Explore
regulatory T cell	20 studies	30% ± 6%	Explore
mast cell	19 studies	36% ± 15%	Explore
plasmacytoid dendritic cell	17 studies	32% ± 11%	Explore
basal cell	17 studies	29% ± 14%	Explore
monocyte	16 studies	32% ± 7%	Explore
endothelial cell of lymphatic vessel	16 studies	35% ± 9%	Explore
connective tissue cell	15 studies	43% ± 14%	Explore
epithelial cell	15 studies	41% ± 21%	Explore
gamma-delta T cell	15 studies	30% ± 13%	Explore
mature NK T cell	14 studies	28% ± 5%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	13 studies	27% ± 9%	Explore
myofibroblast cell	13 studies	41% ± 15%	Explore
CD16-positive, CD56-dim natural killer cell, human	12 studies	29% ± 8%	Explore
capillary endothelial cell	12 studies	27% ± 7%	Explore
ciliated cell	12 studies	37% ± 15%	Explore
dendritic cell	11 studies	36% ± 24%	Explore
CD8-positive, alpha-beta memory T cell	11 studies	28% ± 9%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	30% ± 9%	Explore
vein endothelial cell	11 studies	25% ± 7%	Explore
endothelial cell of vascular tree	11 studies	34% ± 8%	Explore
erythrocyte	10 studies	36% ± 17%	Explore
CD4-positive, alpha-beta memory T cell	10 studies	26% ± 8%	Explore
CD16-negative, CD56-bright natural killer cell, human	10 studies	27% ± 7%	Explore
endothelial cell of artery	10 studies	27% ± 6%	Explore
glutamatergic neuron	10 studies	29% ± 15%	Explore
mucosal invariant T cell	10 studies	26% ± 6%	Explore
platelet	9 studies	27% ± 7%	Explore
abnormal cell	9 studies	29% ± 12%	Explore
myeloid cell	9 studies	32% ± 17%	Explore
secretory cell	9 studies	29% ± 11%	Explore
plasma cell	8 studies	28% ± 11%	Explore
leukocyte	8 studies	31% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	8 studies	32% ± 12%	Explore
neuron	8 studies	54% ± 25%	Explore
hematopoietic stem cell	8 studies	33% ± 14%	Explore
type I pneumocyte	7 studies	30% ± 11%	Explore
plasmablast	7 studies	38% ± 22%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	23% ± 5%	Explore
epithelial cell of proximal tubule	7 studies	30% ± 11%	Explore
mesothelial cell	7 studies	45% ± 18%	Explore
T follicular helper cell	7 studies	31% ± 4%	Explore
GABAergic neuron	7 studies	28% ± 12%	Explore
interneuron	7 studies	36% ± 24%	Explore
type II pneumocyte	6 studies	33% ± 13%	Explore
kidney loop of Henle epithelial cell	6 studies	34% ± 3%	Explore
progenitor cell	6 studies	38% ± 15%	Explore
retinal rod cell	6 studies	39% ± 19%	Explore
astrocyte	6 studies	32% ± 16%	Explore
precursor B cell	6 studies	51% ± 13%	Explore
innate lymphoid cell	6 studies	29% ± 5%	Explore
cardiac muscle cell	6 studies	36% ± 12%	Explore
oligodendrocyte precursor cell	6 studies	34% ± 16%	Explore
alveolar macrophage	5 studies	26% ± 7%	Explore
hematopoietic precursor cell	5 studies	42% ± 23%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	26% ± 3%	Explore
mononuclear phagocyte	5 studies	31% ± 16%	Explore
renal alpha-intercalated cell	5 studies	45% ± 6%	Explore
amacrine cell	5 studies	45% ± 21%	Explore
pro-B cell	5 studies	36% ± 12%	Explore
brush cell	5 studies	51% ± 17%	Explore
immature B cell	5 studies	40% ± 7%	Explore
neutrophil	4 studies	19% ± 2%	Explore
pancreatic A cell	4 studies	58% ± 5%	Explore
type B pancreatic cell	4 studies	60% ± 6%	Explore
exhausted T cell	4 studies	32% ± 9%	Explore
kidney distal convoluted tubule epithelial cell	4 studies	47% ± 14%	Explore
enterocyte	4 studies	23% ± 4%	Explore
enteroendocrine cell	4 studies	42% ± 18%	Explore
ON-bipolar cell	4 studies	43% ± 30%	Explore
retinal ganglion cell	4 studies	77% ± 22%	Explore
megakaryocyte	4 studies	34% ± 15%	Explore
retina horizontal cell	4 studies	53% ± 17%	Explore
retinal cone cell	4 studies	54% ± 26%	Explore
microglial cell	4 studies	24% ± 10%	Explore
adventitial cell	4 studies	33% ± 13%	Explore
Mueller cell	4 studies	39% ± 16%	Explore
muscle cell	4 studies	29% ± 17%	Explore
intermediate monocyte	4 studies	40% ± 20%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	36% ± 13%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	32% ± 4%	Explore
granulocyte	4 studies	39% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	24% ± 3%	Explore
pancreatic D cell	3 studies	56% ± 3%	Explore
glomerular endothelial cell	3 studies	25% ± 6%	Explore
goblet cell	3 studies	31% ± 19%	Explore
neural crest cell	3 studies	49% ± 11%	Explore
retinal bipolar neuron	3 studies	52% ± 21%	Explore
OFF-bipolar cell	3 studies	51% ± 28%	Explore
GABAergic amacrine cell	3 studies	33% ± 13%	Explore
glycinergic amacrine cell	3 studies	26% ± 10%	Explore
erythroblast	3 studies	42% ± 27%	Explore
lymphocyte	3 studies	38% ± 12%	Explore
club cell	3 studies	30% ± 12%	Explore
retinal pigment epithelial cell	3 studies	37% ± 23%	Explore
rod bipolar cell	3 studies	40% ± 14%	Explore
germinal center B cell	3 studies	37% ± 8%	Explore
CD4-positive helper T cell	3 studies	28% ± 9%	Explore
myoepithelial cell	3 studies	42% ± 3%	Explore
pancreatic ductal cell	3 studies	53% ± 7%	Explore
glial cell	3 studies	39% ± 21%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 12%	Explore
melanocyte	3 studies	32% ± 12%	Explore
T-helper 17 cell	3 studies	21% ± 3%	Explore
oligodendrocyte	3 studies	27% ± 4%	Explore
T-helper 1 cell	3 studies	22% ± 5%	Explore
double negative thymocyte	3 studies	45% ± 18%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	16 studies	33% ± 13%	Explore
lung	14 studies	33% ± 10%	Explore
brain	13 studies	26% ± 11%	Explore
eye	9 studies	40% ± 18%	Explore
intestine	8 studies	34% ± 18%	Explore
kidney	8 studies	31% ± 5%	Explore
bone marrow	5 studies	22% ± 7%	Explore
uterus	5 studies	42% ± 12%	Explore
liver	5 studies	33% ± 24%	Explore
lymph node	5 studies	30% ± 4%	Explore
pancreas	4 studies	52% ± 8%	Explore
placenta	4 studies	21% ± 4%	Explore
heart	4 studies	24% ± 6%	Explore
breast	4 studies	31% ± 6%	Explore
adrenal gland	3 studies	22% ± 3%	Explore
thymus	3 studies	43% ± 14%	Explore
prostate	3 studies	27% ± 7%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
ovary	100%	4636.12	180 / 180	100%	83.58	430 / 430
uterus	100%	3423.01	170 / 170	100%	71.34	459 / 459
brain	100%	4297.73	2639 / 2642	100%	117.52	705 / 705
lung	100%	3619.38	577 / 578	100%	54.90	1155 / 1155
esophagus	100%	2545.22	1441 / 1445	100%	51.43	183 / 183
stomach	100%	2629.55	359 / 359	100%	54.19	285 / 286
adrenal gland	100%	3591.72	258 / 258	100%	95.21	229 / 230
thymus	100%	2860.92	651 / 653	100%	92.79	604 / 605
skin	100%	2126.66	1808 / 1809	99%	76.10	469 / 472
breast	100%	3250.72	459 / 459	99%	62.41	1110 / 1118
bladder	100%	3164.43	21 / 21	99%	58.77	500 / 504
prostate	100%	2629.19	244 / 245	100%	58.51	500 / 502
kidney	100%	3379.90	89 / 89	99%	57.64	892 / 901
liver	100%	1477.28	225 / 226	99%	49.74	403 / 406
intestine	100%	3099.18	966 / 966	99%	57.94	520 / 527
pancreas	97%	1381.99	317 / 328	100%	70.99	178 / 178
adipose	100%	3469.67	1204 / 1204	0%	0	0 / 0
blood vessel	100%	3979.79	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	53.67	80 / 80
lymph node	0%	0	0 / 0	100%	92.50	29 / 29
muscle	100%	3850.73	803 / 803	0%	0	0 / 0
spleen	100%	2989.51	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	53.02	45 / 45
ureter	0%	0	0 / 0	100%	20.25	1 / 1
peripheral blood	100%	3291.61	926 / 929	0%	0	0 / 0
heart	99%	9533.93	853 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

GO_0006446	Biological process	regulation of translational initiation
GO_0006413	Biological process	translational initiation
GO_0005575	Cellular component	cellular_component
GO_0016282	Cellular component	eukaryotic 43S preinitiation complex
GO_0003743	Molecular function	translation initiation factor activity
GO_0043024	Molecular function	ribosomal small subunit binding
GO_0005515	Molecular function	protein binding
GO_0003723	Molecular function	RNA binding

Gene name	EIF1B
Protein name	Eukaryotic translation initiation factor 1B, isoform CRA_a (GC20 protein) (cDNA, FLJ92189, Homo sapiens translation factor sui1 homolog (GC20), mRNA) Eukaryotic translation initiation factor 1b (eIF1b) (Protein translation factor SUI1 homolog GC20)
Synonyms	GC20 hCG_16417
Description	FUNCTION: Probably involved in translation.
Accessions	O60739 Q6FG85 ENST00000232905.4

EIF1B report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review